10.1016/j.ajpath.2024.12.003 63 TangH.LuY.OkunM
Read Full Article 3
Mounjaro and Zepbound are once-weekly injectable medications designed to mimic the effects of natural hormones that regulate blood sugar, appetite, and metabolism
Researchers from University of Oxford, University of Dundee, University of Copenhagen, University of British Columbia, Churchill Hospital, Newcastle University, University of Bath and University of Exeter also contributed to the work
Clinical trials show tirzepatide produces 2022% weight loss versus 1518% for semaglutide at comparable doses, making it a logical next step for plateau-resistant patients
Feel more confident 5 reduction of waist circumference after only 13 weeks Reach your goal weight 21% average weight loss at 39 weeks Improve your health 73% eliminated risk of developing Metabolic Syndrome at 52 weeks Decrease in body weight Hear from our patients Rick Jamie Steven